Delivery Order SPE2DR25D1202-SPE2DR26F74FK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,060.19 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on January 18, 2026, with an ultimate completion date of January 20, 2026, represents a firm fixed-price purchase under a non-set-aside competitive procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,492.78 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's parent company, Cencora, Inc., which holds a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,854.29 on January 19, 2026, for the supply of Phenobarbital 65mg tablets (25-count packages) to the Defense Logistics Agency. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was competitively awarded without any set-aside designation. The contract represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials valued at $2,123.64 under a firm fixed price contract. The award was made on November 17, 2025, with an ultimate completion date of November 18, 2025, and is classified as a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,772.04 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL in vial form. This non-set-aside, competitively awarded contract was issued on January 16, 2026, with an ultimate completion date of January 20, 2026. The pharmaceutical product will be delivered to the awardee's location in Conshohocken, Pennsylvania. This delivery order is structured as a firm fixed-price contract, reflecting DLA's standard...
- The Defense Logistics Agency awarded a $6,483.54 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vial on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This...
- The Defense Logistics Agency awarded a $3,410.16 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Phenobarbital 130 mg/mL in vial form. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for the award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,839.58 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 22, 2025, and represents a single delivery order under AmerisourceBergen's larger federal contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,837.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/ml vial on December 31, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74FKDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp on January 22, 2026, for the supply of Phenobarbital 130 mg/ml vials with a ceiling value of $1,060.19. This firm fixed-price delivery order is non-competitive and will be completed by January 23, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (formerly Amerisourcebergen), a major pharmaceutical distributor and healthcare solutions provider. The parent company holds an expanded Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, demonstrating the company's critical role in supplying pharmaceutical products and medical supplies across multiple therapeutic domains to federal military and veteran healthcare systems. The supply of phenobarbital, a barbiturate used for seizure management and other neurological conditions, reflects the company's extensive portfolio in delivering essential medications to support military treatment facilities and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/21/26 |